Health
The Frequency School Launches First 'World Frequency Day' on 11/11 to spread global unity through music and wellness
* New international day aims to raise awareness about positive impacts of sound frequencies on mental and physical health * Declared by the Frequency School, a global initiative by U.S. Grammy-nominated producerMaejor to promote music therapy and wellness around the globe * World Frequency ...
2025-11-11 18:11
1301
MGI Tech Joins Forces with SAMRC and DSTI to Launch South Africa's 110K Human Genome Program and Unveil Africa's First DNBSEQ-T7, Ushering a New Era in African Genomics
CAPE TOWN, South Africa, Nov. 11, 2025 /PRNewswire/ -- MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent's first DNBSEQ-T7 s...
2025-11-11 17:40
986
Apollo Cancer Centres Turns Chocolates into Health Reminders with 'Check-Olate'
NEW DELHI, Nov. 11, 2025 /PRNewswire/ -- To observe this year's Breast Cancer Awareness Month, Apollo Cancer Centres (ACCs) recently launched acrossIndia a unique initiative that blended indulgence with awareness through'Check-Olate', a sweet treat that carries an even sweeter reminder: take a mo...
2025-11-11 17:15
940
Guo Guangchang: Fosun Strengthens Globalization Capabilities, Accelerates Innovation through Open Cooperation
HONG KONG, Nov. 11, 2025 /PRNewswire/ -- On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At this crucial juncture today,China's pharmaceutical innovation ...
2025-11-11 15:41
1957
OMNIBOT Showcases How Connectivity Expands Possibilities in Live Telesurgery at Chilean Urology Congress
-The live telesurgery took place during the XLVI Annual Congress of the Chilean Society of Urology, which also marked the Society's 100th anniversary. This procedure highlights how network connectivity is enabling new forms of surgical collaboration. SINGAPORE, Nov. 11, 2025 /PRNewswire/ -- Duri...
2025-11-11 13:00
1155
NOVI Health Launches "It Starts with One: Taking Charge This World Diabetes Month" Campaign to Support Awareness and Wellness in Singapore
SINGAPORE, Nov. 11, 2025 /PRNewswire/ -- In recognition of Diabetes Awareness Month, NOVI Health is honoured to launch"It Starts with One: Taking Charge This World Diabetes Month", a campaign dedicated to raising awareness, promoting healthy living, and supporting the diabetes community inSingapo...
2025-11-11 11:00
1293
Molly Ally - a Plant-Based Ice Cream Success from Passion and Pain Points
BANGKOK, Nov. 11, 2025 /PRNewswire/ -- Molly Ally
2025-11-11 10:41
1145
Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
RAICHUR, India, Nov. 11, 2025 /PRNewswire/ -- Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), has been awarded the prestigiousGold Medal by EcoVadis, the world's most trusted provider of business sustainability ratings. The com...
2025-11-11 09:15
891
GLAC Biotech Wins Double Honors at the iSEE Global Innovation Awards Lactobacillus plantarum PL-02 Sets a New Benchmark for Functional Probiotics
TAIPEI, Nov. 11, 2025 /PRNewswire/ -- GLAC Biotech, a leading innovator in probiotics and postbiotics research, proudly announces another milestone on the global stage. Its flagship strain,Lactobacillus plantarum PL-02, has been honored withtwo major awards at the 7th iSEE Global Innovation Award...
2025-11-11 09:00
963
Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) announced the successfu...
2025-11-11 09:00
909
Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics
* VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial * New insights into vascular anatomy made possible by standardized image acquisition and reporting * VxWave System has the potential t...
2025-11-11 05:32
1173
LiberNovo Launches Black Friday Savings: Redefine Your Workspace for Health
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- The season for serious deals has
arrived, and LiberNovo today launched its Black Friday & Cyber Monday (BFCM)
sale across across the U.S. and Canada—with limited-time discounts of up to 34%
on its flagship product,the LiberNovo Omni
2025-11-11 00:00
1561
TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives
TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry Adoption, and Superior Service BOSTON, Nov. 10, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestr...
2025-11-10 23:00
1071
Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B
* Cohort 4 follow-up confirms durable hepatitis B surface antigen (HBsAg) loss at 24 weeks post end of treatment (EOT) in BRII-179 anti-HBs responders treated with elebsiran plus pegylated interferon alfa (PEG-IFNα) * Data suggest the potential to shorten PEG-IFNα treatment duration for BRII-...
2025-11-10 21:30
2015
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism targeting NEK7 and NLRP3 inflammasomes shows promise across multiple myeloid neoplasms – - Preclinical data reveal potential applications in hemolyti...
2025-11-10 21:15
1043
Tiumbio to Present First Clinical Data for Dual TGF-β/VEGF Inhibitor Tosposertib (TU2218) at SITC 2025, "Robust Response Rate"
* 70.6% Partial Response and 82.4% Disease Control Rate Observed in Interim Phase II Data SEONGNAM, South Korea, Nov. 10, 2025 /PRNewswire/ -- On Friday, 7 November (local time) at the Society for Immunotherapy of Cancer (SITC) 2025 annual meeting, Tiumbio Co., Ltd. (KOSDAQ: 321550), a clinical...
2025-11-10 21:00
1279
Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo
BOSTON, Nov. 10, 2025 /PRNewswire/ -- Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo duringNovember 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics that power qPCR/RT-qPCR, Isothermal Amplification, and Next-...
2025-11-10 20:30
944
Simcere's IL-2 Mutant Fusion Protein SIM0278 Entered Phase II Clinical Trial Stage
NANJING, China, Nov. 10, 2025 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells（Treg）-preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278, has officially entered a Phase II clinical study inChina for the treatment of moderate-to-severe atopi...
2025-11-10 20:06
1062
Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech
BEIJING, Nov. 10, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong Shunfeng Biotechnology Co., Ltd. ("Shunfeng BioTech") for the Cas...
2025-11-10 20:00
845
LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)
SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- LISCure Biosciences
2025-11-10 20:00
818
Week's Top Stories
Most Reposted
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 312 media titles]
2025-11-27 07:25World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 296 media titles]
2025-12-03 09:00
SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 295 media titles]
2025-11-29 09:00
Blackpanda and ST Engineering Partner to Strengthen Cyber Incident Response Across Asia
[Picked up by 285 media titles]
2025-12-03 14:27
MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand
[Picked up by 284 media titles]
2025-12-01 08:30Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2766
